GXMC
UTHR icon

Global X Management Company’s United Therapeutics UTHR Stock Holding History

Global X Management Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$47K Buy
417
+150
+56% +$16.5K ﹤0.01% 1114
2018
Q1 		$30K Buy
267
+10
+4% +$1.27K ﹤0.01% 1083
2017
Q4 		$38K Buy
257
+66
+35% +$8.39K ﹤0.01% 954
2017
Q3 		$22K Buy
191
+6
+3% +$766 ﹤0.01% 1057
2017
Q2 		$24K Buy
185
+8
+5% +$998 ﹤0.01% 1110
2017
Q1 		$24K Buy
+177
New +$26.8K ﹤0.01% 1041

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Global X Management Company's UTHR Position: Q2 2018 in Review

Global X Management Company increased its United Therapeutics (UTHR) stake by 56% in Q2 2018, buying an estimated $16.5K and bringing the position to 417 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Global X Management Company first reported a position in UTHR in Q1 2017 and has held it in 6 quarters since. 374 funds tracked by Wall St. Rank hold UTHR as of Q2 2018.

  • Global X Management Company held 417 shares of United Therapeutics worth $47K as of Q2 2018.
  • Global X Management Company bought 150 United Therapeutics shares in Q2 2018, an estimated $16.5K.
  • United Therapeutics made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1114 holding.
  • Global X Management Company first reported a position in United Therapeutics in Q1 2017 and has held it in 6 quarters since.
  • 374 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.